Answers are grounded in this paper and cite their sources.
Cross-sectional analysis examines glycemic control in African Americans with diabetes, indicating significant implications of incarceration factors.
Objective. Examine the relationship between incarceration factors and glycemic control in African Americans with criminal legal involvement and type 2 diabetes mellitus (T2DM). Methods. Using a cross-sectional survey analysis of 171 adults, a model was estimated using stepwise regression with forward selection to evaluate the relationship between incarceration factors and glycemic control, controlling for demographic and clinical factors. Results. Reporting a drug-related conviction (β:–0.81; 95%CI:–1.50,–0.11) was associated with higher HbA1c compared with no drug-related conviction. Compared with using only pills or oral hypoglycemic agents, the combination of pills/oral hypoglycemic agents and insulin (β:1.31; 95%CI:0.60,2.01) and using insulin or injectables alone (β:0.94; 95%CI:0.14,1.74) were associated with higher HbA1c. Each additional comorbidity (β:–0.18; 95%CI:–0.33,-0.04) and unit increase in age (β:–0.04; 95%CI:–0.08,–0.01) was associated with a lower HbA1c. Conclusion. History of a drug-related conviction, age, comorbidity, and medication were associated with glycemic control in African Americans with a history of criminal legal involvement and T2DM.
No takes yet. Share an insight, caveat, or question.
Akinboboye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: